`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELAWARE
`_______________________________________
`
`)
`GENENTECH, INC
`)
`
`)
`Plaintiff,
`
`)
`
`
`)
`
`
`)
`
`
`)
`AMGEN, INC.,
`)
`
`
`)
`
`Defendant.
`)
`_______________________________________)
`
`
`
`v.
`
`C.A. No. 18-924-CFC
`
`STIPULATION AND [PROPOSED] ORDER OF DISMISSAL
`WITH RESPECT TO CERTAIN ASSERTED PATENTS
`
`WHEREAS Plaintiff Genentech, Inc. filed a Third Amended Complaint in this case on
`
`September 4, 2019, which asserts infringement of nine patents in connection with Defendant
`
`Amgen Inc. seeking FDA approval for ABP 980 as a trastuzumab biosimilar and marketing that
`
`biosimilar under the trade name Kanjinti (D.I. 347);
`
`WHEREAS Genentech’s Third Amended Complaint includes claims for infringement of
`
`U.S. Patent Nos. 7,993,834, 8,076,066, and 8,440,402;
`
`WHEREAS the Parties desire to streamline the issues in this case for trial;
`
`NOW THEREFORE, it is hereby stipulated and agreed by the Parties, subject to the
`
`approval of the Court, that:
`
`1.
`
`All claims for infringement of U.S. Patent Nos. 7,993,834, 8,076,066, and
`
`8,440,402 (the “Dismissed Patents”) and (Counts VI, VII, and VIII of the Third Amended
`
`Complaint (D.I. 347)) are dismissed with prejudice;
`
`
`
`Case 1:18-cv-00924-CFC Document 361 Filed 09/20/19 Page 2 of 4 PageID #: 26797
`
`2.
`
`All counterclaims for non-infringement, invalidity, and/or unenforceability of the
`
`Dismissed Patents are dismissed without prejudice to Amgen’s ability to raise such claims in a
`
`later action; and
`
`3.
`
`Each Party shall bear its own costs, expenses, and attorneys’ fees associated with
`
`this action with respect to the Dismissed Patents.
`
`This stipulation does not affect the parties’ claims, counterclaims, or defenses with
`
`respect to the remaining patents-in-suit and shall not be admissible at trial in this case for any
`
`purpose with respect to the remaining patents-in-suit. This stipulation is for purposes of this case
`
`only and does not extend to litigation involving any other product between the parties. Neither
`
`party shall use this stipulation for any purpose in litigation between the parties relating to other
`
`products.
`
`
`
`
`
`
`
`2
`
`
`
`Case 1:18-cv-00924-CFC Document 361 Filed 09/20/19 Page 3 of 4 PageID #: 26798
`
`
`
`
`/s/ Neal C. Belgam
`Neal C. Belgam (#2721)
`Eve H. Ormerod (#5369)
`Jennifer M. Rutter (#6200)
`SMITH KATZENSTEIN & JENKINS LLP
`1000 West Street, Suite 1501
`Wilmington, DE 19801
`(302) 652-8400
`nbelgam@skjlaw.com
`eormerod@skjlaw.com
`jrutter@skjlaw.com
`
`OF COUNSEL:
`
`Michelle Rhyu
`Susan Krumplitsch
`Daniel Knauss
`COOLEY, LLP
`3175 Hanover Street
`Palo Alto, CA 94304-1130
`(650) 843-5287
`skrumplitsch@cooley.com
`mrhyu@cooley.com
`dknauss@cooley.com
`
`Orion Armon
`COOLEY, LLP
`380 Interlocken Crescent, Suite 900
`Broomfield, CO 80021-8023
`(720) 566-4119
`oarmon@cooley.com
`
`Eamonn Gardner
`COOLEY, LLP
`4401 Eastgate Mall
`San Diego, CA 92121-1909
`(858) 550-6086
`egardner@cooley.com
`
`
`
`Dated: September 20, 2019
`
`
`
`/s/ Alexandra M. Joyce
`Michael P. Kelly (#2295)
`Daniel M. Silver (#4758)
`Alexandra M. Joyce (#6423)
`MCCARTER & ENGLISH, LLP
`Renaissance Centre
`405 N. King Street, 8th Floor
`Wilmington, DE 19801
`(302) 984-6300
`mkelly@mccarter.com
`dsilver@mccarter.com
`ajoyce@mccarter.com
`
`OF COUNSEL:
`
`William F. Lee
`Lisa J. Pirozzolo
`Emily R. Whelan
`Kevin S. Prussia
`Andrew J. Danford
`WILMER CUTLER PICKERING
`HALE AND DORR LLP
`60 State Street
`Boston, MA 02109
`(627) 526-6000
`william.lee@wilmerhale.com
`lisa.pirozzolo@wilmerhale.com
`emily.whelan@wilmerhale.com
`kevin.prussia@wilmerhale.com
`andrew.danford@wilmerhale.com
`
`Robert J. Gunther Jr.
`WILMER CUTLER PICKERING
`HALE AND DORR LLP
`7 World Trade Center
`250 Greenwich Street
`New York, NY 10007
`(212) 230-8800
`robert.gunther@wilmerhale.com
`
`
`
`
`
`
`
`
`3
`
`
`
`Case 1:18-cv-00924-CFC Document 361 Filed 09/20/19 Page 4 of 4 PageID #: 26799
`
`Daralyn J. Durie
`Adam R. Brausa
`DURIE TANGRI LLP
`217 Leidesdorff St.
`San Francisco, CA 94111
`(415) 362-6666
`ddurie@durietangri.com
`abrausa@durietangri.com
`
`Attorneys for Plaintiff
`Genentech, Inc.
`
`
`
`SO ORDERED this ______ day of ________________, 2019.
`
`Nancy Gettel
`Thomas Lavery, IV
`AMGEN, INC.
`One Amgen Center Drive
`Thousand Oaks, CA 91320-1799
`P 805-447-1000
`ngettel@amgen.com
`tlavery@amgen.com
`
`Attorneys for Defendant Amgen, Inc.
`
`
`
`
`
`
`
`
`
`
`
`
` United States District Judge
`
`
`
`
`
`
`
`4
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
